MedTrace Logo

Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis

NCT01956591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2013-10-08

No results posted yet for this study

Summary

Evaluate the long term efficacy and side effects of oxybutynin in the treatment of hyperhidrosis.

Conditions

  • Hyperhidrosis

Interventions

DRUG

Oxybutynin

All patients are treated with oxybutynin for hyperhidrosis. Usual maintenance dose is 10mg/day, but dose may vary according to weight, efficacy and side effects. Our standard protocol starts with 2.5mg/day in the first 7 days, progresses to 5mg/day for 14 days and then reaches the usual maintenance dose of 10mg/day afterwards.

Sponsors & Collaborators

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Nelson Wolosker, PhD, MD · Hospital Israelita Albert Einstein

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956591 on ClinicalTrials.gov